TP53 and hepatocellular carcinoma: Kitao et al. found that vasodilatation in the arterial phase of dynamic CT and relatively low signal in the hepatobiliary phase of gadoxetic acid-enhanced MRI were independent predictors of TP53-mutated HCC (AUC: 0.770) (41).